ReviewBMJ open gastroenterology2026
Gastric varices: a contemporary review of vascular anatomy and therapeutic strategies.
Review in BMJ open gastroenterology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Gastric varices (GV) are found in 20% of patients with portal hypertension and bleed infrequently, but are associated with greater blood loss, higher transfusion requirements and mortality than oesophageal varices. The vascular anatomy of GV is characterised by different afferent and efferent pathways, which vary depending on its anatomical location. Contemporary radiological classification systems complement traditional endoscopic systems and assist in selection of the optimal treatment modality in an individual patient. Endoscopic cyanoacrylate injection remains the standard therapy for acute GV bleeding and achieves high rates of primary haemostasis, but is limited by incomplete obliteration, recurrent bleeding and risk of systemic embolisation. Endovascular interventions, including transjugular intrahepatic portosystemic shunt and retrograde transvenous obliteration (RTO), have demonstrated superior long-term bleeding control in recent randomised clinical trials, although each has distinct indications and adverse-event profiles (ascites, aggravation of oesophageal varices and hepatic encephalopathy). Endoscopic ultrasound (EUS)-guided interventions enable real-time visualisation of vascular anatomy and targeted treatment with coils, glue or thrombin, resulting in improved obliteration rates and lower recurrence. However, there are limited direct comparisons between these modalities in present literature. The availability of multiple treatment modalities has resulted in the evolution of the management of GV from conventional endoscopic therapy towards individualised, anatomy-driven treatment strategies incorporating EUS-guided and endovascular interventions. This review summarises the contemporary understanding of GV anatomy, pathophysiology and therapeutic strategies.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.